Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: a sequential study
E Zanon, M Milan, G Gamba, C Ambaglio… - Thrombosis …, 2015 - Elsevier
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study
E Zanon, M Milan, G Gamba… - Thrombosis …, 2015 - thrombosisresearch.com
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study.
E Zanon, M Milan, G Gamba, C Ambaglio… - Thrombosis …, 2015 - europepmc.org
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
[PDF][PDF] Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study
E Zanon, M Milan, G Gamba… - Thrombosis …, 2015 - centroemofiliapadova.it
Ezio Zanon a,⁎, Marta Milan a, Gabriella Gamba b, Chiara Ambaglio b, Graziella Saggiorato
c, Luca Spiezia c, Nadia Montani b, Paolo Prandoni aa Department of Cardiac Thoracic and …
c, Luca Spiezia c, Nadia Montani b, Paolo Prandoni aa Department of Cardiac Thoracic and …
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study
E Zanon, M Milan, G Gamba… - Thrombosis …, 2015 - pubmed.ncbi.nlm.nih.gov
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study
E Zanon, M Milan, G Gamba, C Ambaglio… - Thrombosis …, 2015 - infona.pl
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study
E Zanon, M Milan, G Gamba, C Ambaglio… - THROMBOSIS …, 2015 - research.unipd.it
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a …
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study
E Zanon, M Milan, G Gamba, C Ambaglio… - THROMBOSIS …, 2015 - iris.unipv.it
Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex
concentrate (aPCC, Feiba (R)), patients with acquired haemophilia A (AHA) have a …
concentrate (aPCC, Feiba (R)), patients with acquired haemophilia A (AHA) have a …